Skip to content

Hand Jing-Well Points Stimulation to Treat Disorders of Consciousness

A Multi-center Randomised Controlled Trial to Explore the Ideal Stimulation Strategies at Hand Twelve Jing-Well Points in Patients With Disorders of Consciousness

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06927713
Acronym
Wells-DoC
Enrollment
59
Registered
2025-04-15
Start date
2025-05-12
Completion date
2026-06-26
Last updated
2026-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorders of Consciousness Due to Severe Brain Injury

Brief summary

The purpose of this academic lead study is to explore the ideal stimulation strategies at Hand twelve jing-well points in patients with disorders of consciousness.

Interventions

OTHERBloodletting Acupuncture

Bloodletting was applied to the right hand first and then the left hand in the order of Shaoshang (LU 11), Shangyang (LI 1), Zhongchong (PC 9), Guanchong (TE 1), Shaochong (HT 9) and Shaoze (SI 1).

DEVICETranscutaneous electrical stimulation

Transcutaneous electrical acupoint stimulation at hand twelve jing-well points.

Sponsors

Xijing Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age: 18-80 years old * From 7 to 90 days since brain injury * Diagnosed in VS/UWS or MCS as defined by at least two CRS-R assessments performed during the screening period * Acquired cerebral damage of known etiology * Intact hand skin * Informed consent given by the legal surrogate

Exclusion criteria

* Patients who continuously receive sedative drugs and Na+ or Ca2+ channel blockers (e.g., carbamazepine) or NMDA receptor antagonists (e.g., dextromethorphan) * History of previous serious、progressive neurological disorder prior to the brian injury * Epilepsy and seizure * Unstable vital signs or life-threatening comorbidities * Active implant (e.g., cardiac pacemakers/defibrillators, deep brain stimulators, ventriculoperitoneal shunt, etc) * Documented pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Coma Recovery Scale-Revised (CRS-R) changebaseline, immediately after the end of the 5-day treatmentCRS-R score ranges from 0 to 23, with higher scores mean a better outcome.

Secondary

MeasureTime frameDescription
ABCD model changebaseline, immediately after the end of the 5-day treatmentThis model classifies the power spectrum of resting-state EEG data into four categories: A, B, C, and D. Type A exhibits a power spectrum peak in the delta range (0-4 Hz), indicative of a completely disconnected thalamocortical network. Type B shows a primary power spectrum peak in the theta range (4-8 Hz), reflecting a severely disconnected thalamocortical network. Type C exhibits power spectrum peaks in both the theta (4-8 Hz) and beta (13-24 Hz) ranges, indicative of a moderately disconnected thalamocortical network. Type D shows power spectrum peaks in the alpha (8-13 Hz) and beta ranges, representing a fully intact thalamocortical network.
Coma Recovery Scale-Revised (CRS-R) changebaseline, immediately after the end of the first treatmentCRS-R score ranges from 0 to 23, with higher scores mean a better outcome.
Glasgow Outcome Scale-Extended (GOSE)at six months post enrollmentA GOSE score of 1 indicates death, 2 indicates a vegetative state, 3 to 4 indicates severe disability, 5 to 6 indicates moderate disability, and 7 to 8 indicates good recovery. Favorable functional outcome is defined as an GOSE score of 4-8, while unfavorable functional outcome is defined as an GOSE score of 1-3.
Consciousness level changebaseline, at six months post enrollmentThe level of consciousness was evaluated using CRS-R score. Patients who transitioned from UWS to MCS (UWS-MCS) or to emergence from MCS (EMCS) (UWS-EMCS), from MCS minus to MCS plus (MCS - -MCS + ) or to EMCS (MCS - -EMCS), and from MCS to EMCS (MCS-EMCS) were categorized in the improved consciousness group. The unimproved consciousness was defined as a reduced or unchanged level of consciousness.
Correlation between EEG responsiveness and long-term outcomeson the first day, the fifth day and at six months post enrollmentEEG responsiveness to the treatment was considered positive if, after the hand Jing-Well points stimulation, patients exhibited elevated levels of EEG "ABCD" patterns compared to the baseline after either the first or fifth stimulation session. The correlation between EEG responsiveness and long-term consciousness improvement and favorable functional outcome was assessed.
Incidence of Adverse Eventsfrom the first treatment to the end of the fifth treatmentThe incidence of adverse events occurred during the intervention period, including treatment intolerance:painful facial expressions, moans, crying, and head movements;Local adverse effect:skin infections (redness, swelling, suppuration), subcutaneous ecchymosis, skin burns (blisters or eschar formation);Systemic adverse effect:epileptic seizures。

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026